With nearly seven million people currently living with Alzheimer's in the US, advocates stress the urgency of finding a cure, ...

Dear Eric: My husband had Alzheimer’s and spent his last couple of years in memory care in a retirement community where many ...

Asking Eric addresses grief, changing friendships, and navigating disappointment after loss. Learn how to protect your ...

Dear Eric: My husband had Alzheimer’s and spent his last couple of years in memory care in a retirement community where many ...

Subtle changes in brain activity in the presence of both amyloid-beta and tau proteins may point to Alzheimer's disease, long ...

"We had been very close to these folks in the past, and my husband remained so delighted to see them, even if he couldn’t ...

Kisunla (donanemab) is the second in a new generation of amyloid-targeting medicines to reach the Japanese market after Eisai ...

Eli Lilly has received approval in Japan for Kisunla (donanemab-azbt) to treat early symptomatic Alzheimer's disease.

Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing ...

Leptin, a hormone that helps with weight control, also plays a role in normal cognition. Leptin resistance occurs when the ...

Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...

Join the Walk to End Alzheimer's on October 5, 2024 at the National WWI Museum and Memorial. Learn more about this and other ...